Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Revolution Medicines, Inc.
H. Lee Moffitt Cancer Center and Research Institute